| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc. | EVP, CFO & Treasurer | Common Stock | 85,105 | $536,161 | $6.30 | 03 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | 03 Feb 2026 | 1 | -$10,244 | 4 | EVP, CFO & Treasurer | 04 Feb 2026, 16:11 |
| KPTI | Karyopharm Therapeutics Inc. | 31 Jan 2026 | 1 | $0 | 4 | EVP, CFO & Treasurer | 03 Feb 2026, 16:29 |
| KPTI | Karyopharm Therapeutics Inc. | 15 Oct 2025 | 1 | $0 | 4 | EVP, CFO & Treasurer | 16 Oct 2025, 16:25 |
| KPTI | Karyopharm Therapeutics Inc. | 31 Jan 2025 | 2 | $0 | 4 | EVP, CFO & Treasurer | 03 Feb 2025, 16:15 |
| KPTI | Karyopharm Therapeutics Inc. | 03 Jan 2025 | 0 | $0 | 3 | EVP, CFO & Treasurer | 06 Jan 2025, 17:07 |